SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sergio H who wrote (20958)9/18/2000 8:30:50 PM
From: RCJIII  Read Replies (2) of 29382
 
Amigos, check out BIPL. Profitable tiny genomics play with cash on the books, no debt and a clean balance sheet.

.07 in earnings in the last two quarters. (.02 and .05)

Sales rose 20% last quarter to $2,834,000.

Income rose 204% to $389,000.

8.3 million shares outstanding.

5.90 in the float.

They make diagnostic products to assess and diagnose various ailments and conditions.

They just closed a merger with Xtrana, a private company with technology used by genomics companies.

Their technology allows for extremely fast and reliable testing of RNA and DNA.

They just launched a new DNA test that they are very excited about.

They also should soon unveil a new very fast testing device for HIV.

Many other tests are in the works.

This is an interesting little company with great prospects. In genomics research, speed is everything and this company can help speed along several important tests.

The chart looks very compelling as well. In a very strong uptrend. Moved up nicely today in a very bad market.

I have been buying shares recently. I think it looks great.

RCJIII
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext